ID: ALA5291154

Max Phase: Preclinical

Molecular Formula: C19H20FN5O3S

Molecular Weight: 417.47

Associated Items:

Representations

Canonical SMILES:  C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(-c4nnc(S)o4)cn1c23

Standard InChI:  InChI=1S/C19H20FN5O3S/c1-10-9-27-17-14-11(7-13(20)15(17)24-5-3-23(2)4-6-24)16(26)12(8-25(10)14)18-21-22-19(29)28-18/h7-8,10H,3-6,9H2,1-2H3,(H,22,29)/t10-/m0/s1

Standard InChI Key:  YRLGBNYSGBAJRH-JTQLQIEISA-N

Associated Targets(Human)

HL-60 67320 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

SMMC-7721 5516 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

CHO 4503 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 417.47Molecular Weight (Monoisotopic): 417.1271AlogP: 2.18#Rotatable Bonds: 2
Polar Surface Area: 76.63Molecular Species: NEUTRALHBA: 9HBD: 1
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: 6.64CX Basic pKa: 5.94CX LogP: 1.35CX LogD: 0.94
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.64Np Likeness Score: -0.67

References

1. Ahadi H, Emami S..  (2020)  Modification of 7-piperazinylquinolone antibacterials to promising anticancer lead compounds: Synthesis and in vitro studies.,  187  [PMID:31881454] [10.1016/j.ejmech.2019.111970]

Source